CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science
- Written by C. Michael White, Distinguished Professor of Pharmacy Practice, University of Connecticut
So many diseases to treat, so little money and time.Andriy Onufriyenko/Moment via Getty ImagesPrescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical industry decide which...